title: Different preparation methods to obtain platelet components as a source of growth factors for local application.
abstract: BACKGROUND
  Autologous platelet components were recently used as part of tissue-engineering strategies in oral and maxillofacial surgery. Various preparation methods were investigated to define standardized blood bank components and to collect data on the growth factor content of human platelets before and after storage.
  
  
  METHODS
  Apheresis platelets (AP), buffy coat-derived platelets (BCP), platelets prepared by tube method (TP), and highly concentrated samples prepared from AP and from BCP were evaluated for standard quality criteria of platelet components and for their concentration of transforming growth factor (TGF)-ss1, platelet-derived growth factor (PDGF)-AB, and PDGF-BB. AP were stored for 5 days. On Days 3 and 5, these components and freshly prepared, highly concentrated samples were evaluated for the same measures.
  
  
  RESULTS
  Platelet concentration in TP was lower than that in the other groups (p<0.05). However, the concentrations of PDGF-AB, PDGF-BB, and TGF-ss1 were comparable in the three groups. TP showed higher spontaneous CD62 expression than did AP and BCP. The three preparation procedures resulted in significantly different WBC contamination, with the highest levels in TP. For the whole series of measurements, there was a strong correlation between growth factor levels and platelet concentration (p<0.05), which was due to the face that the growth factor content of concentrated platelet samples was tenfold that of AP, BCP, and TP. In TP, the WBC concentration was correlated with PDGF levels (p<0.05). After 5-day storage, the mean levels of PDGF-AB, PDGF-BB, and TGF-ss1 were 57.1, 43.0, and 72.0 percent of the initial values in AP. Overall, multiple regression analysis revealed the following factors influencing the measured growth factor concentrations: platelet concentration, baseline CD62 expression, lactate production, and WBC contamination.
  
  
  CONCLUSIONS
  Various methods enable the preparation of platelet components and of highly concentrated components for local use according to standard blood banking criteria. The obtained components differ, particularly in their WBC content and in vitro platelet activation. These findings are relevant for planning and evaluating further studies of locally usable autologous platelet components.
authors.affiliation: Department of Transfusion Medicine, Friedrich Alexander University Erlangen-Nürnberg, Erlangen, Germany. robert.zimmermann@trans.imed.uni-erlangen.de
authors.forename: R
authors.initials: R
authors.lastname: Zimmermann
authors.forename: R
authors.initials: R
authors.lastname: Jakubietz
authors.forename: M
authors.initials: M
authors.lastname: Jakubietz
authors.forename: E
authors.initials: E
authors.lastname: Strasser
authors.forename: A
authors.initials: A
authors.lastname: Schlegel
authors.forename: J
authors.initials: J
authors.lastname: Wiltfang
authors.forename: R
authors.initials: R
authors.lastname: Eckstein
mesh_terms: D001792:Blood Platelets / Q000737:chemistry*; D001793:Blood Preservation / Q000379:methods; D006133:Growth Substances / Q000097:blood*; D006801:Humans; D008722:Methods; D015539:Platelet Activation; D010982:Platelet-Derived Growth Factor / Q000032:analysis; D010983:Plateletpheresis / Q000379:methods* / Q000592:standards; D015291:Transforming Growth Factors / Q000032:analysis
chemical_list: D006133:Growth Substances; D010982:Platelet-Derived Growth Factor; D015291:Transforming Growth Factors